期刊： PHARMACOECONOMICS, 2022; 40 (3)
Objectives We aimed to elicit preferences of the French-speaking Quebec population regarding a COVID-19 vaccination program and to characterize indivi......
期刊： PHARMACOECONOMICS, 2022; 40 (7)
Background and Objectives Valuing children's health states for use in economic evaluations is globally relevant and is of particular relevance in juri......
期刊： PHARMACOECONOMICS, 2022; 40 (11)
Health economic analyses are essential for health services research, providing decision-makers and payers with evidence about the value of interventio......
期刊： PHARMACOECONOMICS, 2022; 40 (4)
Background Socioeconomic status has an important effect on cardiovascular disease (CVD). Data on the economic implications of CVD by socioeconomic sta......
期刊： PHARMACOECONOMICS, 2022; 40 (12)
Endometriosis is a chronic inflammatory disease that can have serious physical and emotional consequences for patients in terms of pain, quality of li......
期刊： PHARMACOECONOMICS, 2022; 40 (SUPPL 1)
Background Spinal muscular atrophy (SMA) is a rare, progressive neuromuscular disease that affects individuals with a broad age range. SMA is typicall......
期刊： PHARMACOECONOMICS, 2022; 40 (2)
The use of population averages in cost-effectiveness analysis may hide important differences across subgroups, potentially resulting in suboptimal res......
期刊： PHARMACOECONOMICS, 2022; 40 (SUPPL 1)
Background Spinal muscular atrophy (SMA) is a severe neuromuscular disease that is inherited in an autosomal recessive manner with an estimated incide......
期刊： PHARMACOECONOMICS, 2022; 40 (5)
Preferences for child and adolescent health states used to generate health state utility values can be elicited from adults, young adults, adolescents......
期刊： PHARMACOECONOMICS, 2022; 40 (9)
Background The international protocol for valuing EQ-5D-5L focuses upon prescribed preference elicitation methods and design. However, there are no re......
期刊： PHARMACOECONOMICS, 2022; 40 (9)
Background and Objective Best-worst scaling is a theory-driven method that can be used to prioritize objects in health. We sought to characterize all ......
期刊： PHARMACOECONOMICS, 2022; 40 (10)
Background and Objective Precision medicine highlights the importance of exploring heterogeneity in the effectiveness and costs of interventions. Our ......
期刊： PHARMACOECONOMICS, 2022; 40 (1)
Many health technology assessment committees have an explicit or implicit reference value (often referred to as a 'threshold') below which new health ......
期刊： PHARMACOECONOMICS, 2022; 40 (2)
Measuring and valuing health-related quality of life (HRQOL) in children can be challenging but is an important component for providing decision maker......
